The purpose of this study was to describe normal characteristics of distortion product otoacoustic emission (DPOAE) signal and noise level in a group of newborns and infants with normal hearing followed longitudinally from birth to 15 months of age.
INTRODUCTION
Distortion product otoacoustic emissions (DPOAEs) recorded in the ear canal are a rapid, noninvasive, preneural measure that provides ear-and frequency-specific information about the integrity of outer hair cell (OHC) function. DPOAEs are able to reliably screen for hearing loss greater than 30 dB HL (Gorga et al. 2000a (Gorga et al. , 2005 . Due to these advantages, DPOAEs are commonly used for screening and diagnosis of hearing status in young infants referred from newborn screening, yet important gaps remain in our understanding of changes in these measures over the first year of life. OHCs are one of the most vulnerable components of the peripheral auditory system and if damaged, can result in hearing loss and a reduction or absence of DPOAE levels. The amount of damage incurred to OHCs is directly related to the degree of DPOAE amplitude reduction (Gorga et al. 2000b) . Thus, understanding the normal amplitude of DPOAEs across a range of frequencies in newborns and infants is important for clinical assessment.
The stimulus level (forward transmission) and the response (reverse transmission) depend upon ear-canal and middle ear acoustic transfer properties. Therefore, immaturities of the external and middle ear can affect both forward transmission of the DPOAE stimulus and reverse measurement of the DPOAE response. While DPOAE suppression tuning curves have revealed generally adult-like tuning and presumably mature OHC function in humans by full-term birth , premature infants have narrower tuning curves at 6 kHz with steeper low-frequency slopes (Abdala 1996) . These immature tuning curves in premature infants have been interpreted to reflect developmental changes that occur in the outer and middle ear that affect DPOAE responses (Abdala & Keefe 2006; Keefe & Abdala 2007) . In contrast to relatively mature cochlear tuning properties, the amplitude of DPOAEs across frequencies is much higher in newborns and infants than in older children and adults, despite the use of in situ calibration to adjust the sound pressure level of the stimuli for the smaller ear-canal volume of infants. This observation is consistent with multiple reports reviewed by Gorga et al. (2000b) , wherein DPOAE amplitude in the pediatric population is significantly larger than the amplitude in adults. To explore underlying reasons for these differences, Keefe and Abdala (2007) modeled forward and reverse transmission of DPOAE input-output functions in infants of full term to 6 months of age. Predictions of forward transmission showed increased attenuation produced by the immature infant ear canal and middle ear relative to the adult ear canal and middle ear. In contrast, predictions for reverse transmission showed an increased level gain by as much as 13 dB in the ear canal and middle ear of infants relative to adults.
From infancy to adolescence, the external and middle ear structures undergo many complex anatomical and physiological developmental changes that could affect DPOAE transmission. In contrast, cochlear anatomy and structure are mature at 26 to 28 gestational weeks, thus postnatal changes in the external and middle ear structures are more likely to affect forward and reverse transmission of otoacoustic emissions, although the precise functional effects of these anatomical changes are poorly understood (Abdala & Keefe 2006) .
Several studies have employed a cross-sectional study design to evaluate DPOAE levels in newborns, infants, children, and adults (Prieve et al. 1997; Lasky 1998; Kon et al. 2000; Abdala & Dhar 2012) . Overall, results from these studies indicate that DPOAE levels from infants are greater than those measured in adults and the results are frequency dependent. DPOAE levels across f 2 frequencies from 0.5 to 4 kHz are the most robust in newborns and infants, and peak at 6 to 8 months of age. DPOAE levels are 5 to 15 dB lower in adults than in infants.
Limited longitudinal data have been obtained to understand development of DPOAE responses during the important period from birth to 1 year of age. Zang and Jiang (2007) examined DPOAEs at f 2 frequencies of 0.5 to 10 kHz in 35 infants at 3 to 5 days after birth, 6 months of age, and 12 months of age. Unfortunately, it is unclear whether DPOAE level or signal to noise ratio (SNR) was measured. They reported "DPOAE levels" that have a similar configuration to SNR, that is, lower levels in the low frequencies, with DPOAE values increasing as the f 2 test frequency increased. The distortion product (DP) levels were much higher than those reported in any other study but were similar to SNR levels reported in other studies. Abdala et al. (2008) conducted a retrospective study of DP grams, defined as "DP level plotted as a function of f 2 frequency" during the preterm and early postnatal period in a series of three experiments that used a combination of cross-sectional and longitudinal design. For the cross-sectional portion of the study, DP grams were recorded in 125 preterm infants categorized based on postconceptual age (31 to 33, 34 to 36, and 37 to 40 weeks), in 118 term infants at birth and 18 term infants at 4.5 weeks of age. They found that DPOAE levels generally increased as infant age increased with the highest responses recorded at 4.5 weeks of age. DPOAE level generally decreased as f 2 frequency increased.
There are limitations to clinical application of published reports on infant DPOAEs thus far. Most studies used a crosssectional study design with small sample sizes and either focused on preterm/term newborns or combined infants across birth to 1 year of age, a time during which many developmental changes occur. The method of DPOAE collection varied among the studies with some using fixed-level primary tones (Lasky 1998; Kon et al. 2000; Zang & Jiang 2007; Abdala et al. 2008; Abdala & Dhar 2012) and others using DPOAE input-output functions (Prieve et al. 1997) . While all studies used an f 2 /f 1 ratio of 1.22, there were a variety of primary levels ranging from 40 to 65 dB SPL and primary SPL differences ranging from 0 dB
In addition, few studies have verified normal middle ear function or normal hearing related to DPOAE results. Diagnostic air and bone conduction tone burst threshold auditory brainstem response (ABR) is the accepted standard for determination of hearing in infants and newborns but has not been measured relative to DPOAE in these previous studies. Prieve et al. (1997) recorded 226 Hz tympanograms; however, for neonates, 226 Hz tympanograms are not able to reliably differentiate normal ears and those with middle ear fluid (Paradise et al. 1976; Marchant et al. 1986) . From birth to 6 months of age, higher probe tone frequencies from 0.66 to 1 kHz are more effective for detection of middle ear fluid (Hunter & Margolis 1992; Baldwin 2006; Zhiqi et al. 2010 ). Zang and Jiang (2007) assessed middle ear function with 226 Hz tympanometry at the 6-and 12-monthold visit. However, middle ear status was not evaluated before recording DPOAEs 3 to 5 days after birth during which time middle ear effusion is common (Roberts et al. 1995; Palva et al. 1999) . Other studies either did not measure tympanograms (Lasky 1998; Abdala et al. 2008) , did not report tympanometry exclusion criteria (Abdala & Dhar 2012) , or did not report tympanometry recording parameters (Kon et al. 2000) . With regard to hearing status, several studies did not verify normal hearing before DPOAE recording (Lasky 1998; Zang & Jiang 2007) . Kon et al. (2000) classified normal hearing as less than 40 dB nHL for infants. Abdala and Dhar (2012) and Abdala et al. (2008) required the infants to pass a click-evoked ABR screen at 35 dB nHL. Prieve et al. (1997) attempted to verify normal hearing with sound field visual reinforcement audiometry (VRA) but were only able to obtain reliable VRA results in 10% of children less than 2 years of age.
Wideband absorbance has been applied to assess middle ear function related to DPOAE screening referrals for newborns (Keefe et al. 2003a; Sanford & Feeney 2008; Sanford et al. 2009; Hunter et al. 2010 ) and conductive hearing loss in infants . In a review of published literature on wideband absorbance, Hunter et al. (2013) reported that infants and children with surgically confirmed otitis media with effusion have lower absorbance in the mid frequencies. Infants who failed DPOAE screenings at birth have lower absorbance from 1 to 3 kHz in the affected ear (Sanford et al. 2009; Hunter et al. 2010) .
To accurately assess cochlear function and reliably detect hearing loss in newborns and infants, normative data are needed from infants with verified normal middle ear function and hearing status using DPOAE test parameters that are currently used in clinical practice. The purpose of the present study was to characterize DPOAE and noise levels in a prospective cohort of newborns and infants with normal hearing followed longitudinally from birth to 15 months of age.
MATERIALS AND METHODS

Subject Enrollment and Demographics
This study was part of a longitudinal, prospective multiyear project to evaluate the use of wideband acoustic absorbance to identify middle ear, cochlear, and neural hearing loss in infants and children. Infants were enrolled from the well-baby nursery (WBN) and neonatal intensive care units (NICUs) at Good Samaritan Hospital and Cincinnati Children's Hospital Medical Center after they completed universal newborn hearing screening (UNHS). The standard UNHS test battery in the WBN was a two-stage protocol that consisted of transient-evoked otoacoustic emission (TEOAE, clicks at 80 dB SPL) followed by an automated ABR (clicks at 35 dB nHL) if the TEOAEs were not passed. Infants enrolled in the NICU were tested with ABR, and either TEOAE or DPOAE. Infants from the WBN were tested within 24 to 48 hr after birth, and infants from the NICUs were tested before discharge. The UNHS yielded overall pass/refer results for each ear.
Infants participated in up to four study visits from birth to 15 months of age. Corrected age at test (defined later) was used to classify results in to one of the following recruitment age ranges: visit 1 (birth to 4 months of age), visit 2 (4 to 7 months of age), visit 3 (7 to 11 months of age), and visit 4 (11 to 15 months of age). At each visit, otoscopy, DPOAE, and wideband absorbance tests were completed, as well as diagnostic tone burst ABR testing at visit 1 and VRA testing at visits 3 and 4. The study was approved by the institutional review board of the Cincinnati Children's Hospital Medical Center and Good Samarian Hospital. Informed consent was obtained from the parent(s) of all infants before enrollment.
Of the 488 infants enrolled in the study, a total of 371 ears from 231 infants (125 male and 106 female) met the normal hearing inclusion requirements. Normal hearing inclusion criteria across the longitudinal visits were strict and included a pass result on the UNHS and normal hearing, verified with both ABR and VRA tests. The ABR and VRA test criteria are described later. All data reported used corrected age (when applicable) where 38 weeks postmenstrual date was considered to be full term. The corrected age was calculated by subtracting the difference between gestational age at birth and 38 weeks from the chronological age.
Test Protocol
An otoscopic examination was performed by the audiologist to assure that the ear canal was patent and to determine the appropriate size impedance probe tip. Wideband absorbance data were acquired using custom research software on a personal computer with a Titan probe and modified AT-235 tympanometry hardware (Interacoustics AT-235 and Titan probe; Middlefart, Denmark). See Keefe et al. (2015) and Hunter et al. (2015) for detailed recording methods and analysis information. Because the ABR and VRA results were the primary diagnostic criteria for hearing status, ears were not excluded on the basis of wideband absorbance results. However, normative absorbance data across the same age range and for the same infants in the present study were reported in Hunter et al. (2016) and were also analyzed in the present study relative to the DPOAE results.
DPOAE testing (2f 1 -f 2 ) was completed with the Vivosonic Integrity system (Version 5.2; Vivosonic Inc., Toronto, ON, Canada) using the ILO P40-UG probe. Clinical DPOAE recording parameters that have been shown to produce the most robust DPOAE in infants and adults were used (Gorga et al. 2003) . Primary tone stimulus levels were set at SPLs of 65 dB (L 1 ) and 55 dB (L 2 ) with a primary tone f 2 /f 1 frequency ratio of 1.22 (Gaskill & Brown 1990; Abdala 1996; Stover et al. 1996) . In situ calibration was performed in each ear using the default program 1-kHz calibration tone before testing followed by a DP gram acquisition. DPOAE f 2 test frequency was measured in descending order at seven frequencies (8, 5.5, 4, 3, 2, 1.5, and 1 kHz) because this is the most common clinical test order. Two trials were measured for each ear, and the trial with the overall better SNR was used for analysis. The SNR was calculated by subtracting the mean DPOAE noise level from the mean DPOAE level at each f 2 test frequency. This means that the calculated SNR was sometimes negative in some ears, and this convention was used in the analyzed results. As a practical matter, negative SNRs might be interpreted as if the SNR was 0 dB because a DPOAE level lower than the DPOAE noise level cannot be accurately measured. The averaging time was set at 12 sec averaging per stimulus pair per trial. The measurement accuracy was set to "accurate" on the Vivosonic device so that the DPOAE level was required to be stable for 0.4 sec within ±1 dB from its median SPL, and the DP signal was required to be within 1 dB of the target level. For signal averaging, the default Kalman weighting algorithm was applied (Vivosonic, Inc.; Toronto, ON, Canada). In this algorithm, the DPOAE level is estimated for each 10 msec epoch, and a discrete Fourier transform at the specific expected DPOAE frequency is calculated. With each subsequent epoch, the frequency specificity of the discrete Fourier transform becomes narrower. The noise is estimated from each epoch, and the noise estimate is used to create a "Kalman weight." The Kalman weight is used to include the response estimate in the total Kalman weighted average. The advantage of Kalman weighting is that artifact rejection is not necessary and the measurement is faster because noisy responses are retained, but weighted less than quiet responses. DPOAEs were included only if data for at least five frequencies were obtained, as occasionally results were not complete at 1 and 1.5 kHz due to excessive infant noise.
At visit 1, diagnostic ABRs were completed within a double-walled sound booth using the Vivosonic Integrity system (Version 5.2; Vivosonic, Inc., Toronto, ON, Canada). Tone burst thresholds were obtained for both air and bone conduction at 1 and 4 kHz, and also at 0.5 and 2 kHz if time and infant state (natural sleep or quietly resting) allowed. Air conduction stimuli were presented with insert earphones (Etymotic Research ER-3A, Elk Grove Village, IL) using pediatric foam ear tips. Bone conduction stimuli were presented with a B-71 bone oscillator (Radioear Corp., New Eagle, PA) hand held to the temporal bone just above the pinna (Yang et al. 1987; Stuart et al. 1990 ). Normal hearing was defined as air and bone conduction thresholds of 30 dB nHL or better at 1 and 2 kHz, and 20 dB nHL or better at 4 kHz. In the early stages of the study before establishment of a normative sample (Elsayed et al. 2015) , 30 dB nHL was set as the normal criterion across all frequencies (Stapells & Oates 1997) , so an additional requirement was added that the latency was required to be within a normal range at 4 kHz if 30 dB nHL was the lowest level tested. See Elsayed et al. (2015) for additional information regarding ABR recording methods and analysis, as well as for normative data from this sample of infants.
At visit 3 and also at visit 4 if results were incomplete at visit 3, VRA testing was performed within a sound booth using the Intelligent Hearing Systems Smart VRA device with insert earphones (Etymotic Research ER-3A, Elk Grove Village, IL) and a Radioear B-71 bone vibrator (Radioear Corp., New Eagle, PA). The protocol used two examiners, and followed the recommended protocol of Widen et al. (2000) , except for a 5 dB adjustment in minimum response level, based on normative data using our system and set-up. The protocol included catch trials to assess false-positive responses. The criteria for normal hearing was a minimum response level of 25 dB HL or better for speech syllables and warble tones between 1 and 4 kHz, with no air-bone gap (air conduction level minus the bone conduction level at the same test frequency) exceeding 10 dB.
Statistical Analysis
Analysis of the longitudinal DPOAE and noise levels was conducted using a linear mixed model with study visit (age range) as a repeated measure to evaluate how DPOAEs changed with age. Due to the complexity of varying number of visits, which could be biased by subjects who did not complete all visits, the linear mixed model analysis was used to examine age effects using procedures to minimize effects of missing data. The restricted maximum likelihood estimation method provides more valid and precise results in terms of missing values, unbalanced and nonnormal data distributions compared with the more conventional analysis of variance or analysis of covariance, and uses all available data in the estimation. For statistical analysis, visit 1 was subdivided into two age ranges (approximately 1 and 2 months) to examine early development. Therefore, a total of five nonoverlapping age ranges, corrected for gestational age at birth, were defined as follows: visit 1a (−0.9 to 1.4 months of age), visit 1b (1.5 to 4.2 months of age), visit 2 (4.7 to 7.4 months of age), visit 3 (7.5 to 10.4 months of age), and visit 4 (10.5 to 14.7 months of age). Note that these age ranges vary slightly from those reported in Table 1 because visit 1 was split into 1-and 2-month analysis age ranges. In addition, data from one ear was randomly selected for the statistical model so that each subject was included only once in the longitudinal sampling. Due to health and scheduling issues, some participants had two visits within the same age range. In such cases, the visit closest to the center of the target age was used.
All analyses were controlled for corrected age and gestational age at birth, nursery group (NICU or WBN), race (Caucasian or not Caucasian), and wideband ambient absorbance at frequencies paired to the closest DPOAE f 2 frequencies.
Significant effects were analyzed using least square means and 95% confidence intervals. A studentized maximum modulus multiple pairwise comparison adjustment was applied as the post hoc test for significant age range effects. This method is more powerful for the problem of missing data in the longitudinal design. Data were analyzed using SAS statistical software, version 9.3 (SAS Institute, Cary, NC). The two-sided significance level was set at 0.05.
RESULTS
A total of 231 infants met inclusion criteria and were included in the total normative sample; 54% were male and 46% were female. The majority of infants were Caucasian (59%), 29% were African-American, and 12% were mixed or Asian. In terms of ethnicity, 2% were Latino. Risk factors for hearing loss included NICU stay >5 days (21%), hyperbilirubinemia (16%), ototoxic drugs (13%), low birth weight (7%), family history (8%), and intrauterine infection (1%). As DPOAEs were measured in both ears at each of four possible visits, a total of 1036 DPOAE measurements were recorded. The primary study outcomes focused on the diagnostic ABR and VRA study visits, thus the majority of the DPOAE measurements were completed at visit 1 (n = 371, 36%) and visit 3 (n = 329, 32%), with fewer tests at visit 2 (n = 174, 17%) and visit 4 (n = 162, 16%). A subset of infants were invited to attend these additional visits (2 and 4) to more fully characterize developmental changes.
The mixed model results are displayed in Table 2 , with the DPOAE and noise levels modeled individually by frequency.
The p values shown in Table 2 are aggregated over the categories included in the model. Wideband absorbance was significantly and positively related to DPOAE levels at 2 to 8 kHz. That is, higher absorbance was related to higher DPOAE levels. Increased corrected age was related to decreased DPOAE levels at 1.5, 4, and 5.5 kHz. Increased corrected age was related to increased noise level at 1, 2, and 3 kHz. On the contrary, gestational age at birth, nursery, or race were not related to DPOAE ). An effect of gestational age at birth on DPOAE level reached significance only at 1.5 kHz and was not related to noise level. With regard to race, DPOAE levels at 5.5 kHz were higher in Caucasian infants and were related to noise at 1.5 kHz only. There were no significant effects of nursery on DPOAE level, while nursery was related to noise at 2 kHz only. While gestational age at birth, nursery, and race were statistically significant at one frequency, overall, there were no systematic effects of these demographic variables. Because the main effects on DPOAE level and noise level were significant for wideband absorbance and corrected age at testing, further analyses focused on these main effects across the five age ranges. Post hoc comparisons showed higher mean DPOAE levels at 4 kHz for visit 1a and visit 1b compared with visits 2, 3, and 4 (Table 3 ). There were no significant differences in mean DPOAE level between visit 1a and visit 1b at any f 2 frequency. At 5.5 kHz, there were significant differences in mean DPOAE level between visits 1a and 1b and 6 months. The mean DPOAE level at visits 2, 3, and 4 was not significantly different at any frequency.
Post hoc analysis indicated that the largest change in DPOAE noise level occurred between visits 1 and 4. The lowest DPOAE noise levels occurred at visits 1a and 1b at most test frequencies (1, 2, 3, 4, and 5.5 kHz) compared with all other age ranges. There were no significant differences in mean DPOAE noise levels between infants 1 and 6 months of age. At 1 kHz, there was a significant difference in mean DPOAE noise levels between 1-and 6-month-olds. At 2 kHz, there was a difference between visits 1 and 4, and at 4 kHz, there was a significant difference between visits 1a and 4 and between visits 1b and 4. No other significant differences were found between age ranges, or for the other frequencies (5.5 and 8 kHz) in noise levels.
The internal consistency or reliability for the DPOAE and noise levels across the seven test frequencies within each individual measurement was estimated using the Cronbach α statistic (Cronbach 1951) , which describes how closely related are a set of items as a group. For clinical application, Cronbach α values higher than 0.8 are recommended (Cronbach 1951) . However, for comparing groups, as in the age ranges for this study, Cronbach α values of 0.7 to 0.8 are regarded as satisfactory. The
Cronbach α for DPOAE level and noise level was 0.76 and 0.71, respectively, which indicated satisfactory reliability. Figure 1 illustrates the model estimated mean DPOAE level (Fig. 1A ) and noise level (Fig. 1B) in infants at each visit as a function of DPOAE f 2 frequency. These model estimates take significant confounding factors into account (mainly wideband absorbance) to examine age effects, controlling for absorbance, race, and nursery. The vertical bars represent the 95% confidence intervals, which are offset for visualization purposes. The configuration of the mean DPOAE level across f 2 frequency was similar for visits 1a and 1b, and similar for visits 2 to 4. At visits 1a and 1b, a peak in DPOAE level was apparent at 1.5 and 4 kHz. However, by visit 2, the peak at 1.5 and 4 kHz disappeared and the mean DPOAE level gradually decreased from 2 to 8 kHz as the f 2 frequency increased. The largest change in DPOAE level, about 5 dB, occurred between visits 1 and 2 in the mid to high frequencies (4, 5.5, 8 kHz). Minimal changes in DPOAE level occurred between visits 2 and 4. The DPOAE noise level displayed a slight, yet systematic increase with age over the first year with the highest noise levels at visit 4 across test frequencies. In general, noise levels were much higher at frequencies below 3 kHz for all visits, and decreased with increasing test frequency. 
Fig. 1. Model estimated mean DPOAE level (A) and noise level (B) in nor-
mal-hearing infants at visits 1 to 4, denoted by the mean ages of 1, 2, 6, 9, and 12 mos, as a function of DPOAE f 2 frequency. Brackets represent the 95% confidence intervals and were offset horizontally for visualization purposes. DPOAE indicates distortion product otoacoustic emission.
As most of the significant differences occurred between visits 1 and 2, the normative data presented focuses on two redefined age ranges: younger infants (0 to 4 months of age from visits 1a and 1b) and older infants (≥5 months of age from visits 2 to 4). Combining into two age ranges is convenient for clinical application, and the results do not support more than two normative age ranges. In addition, because clinical interpretation involves analyzing DPOAE level and SNR, noise levels were not further analyzed. Figure 2 illustrates the raw data for DPOAE level and SNR distributions based on percentile rankings at the younger and older age ranges. The light gray shaded area represents the 10th to 90th percentiles of levels and the dark gray shaded area represents the 20th to 80th percentiles. The dark black line represents the median or 50th percentile. Table 4 provides the raw data in percentiles for the DPOAE level and SNR percentiles (1st, 5th, 10th, 20th, median, 80th, 90th, 95th, 99th) as well as means and standard deviations for infants with normal hearing in the two combined age ranges. Because the 5th percentiles for SNR did not exceed 0 dB for several frequencies, the 10th and 90th percentiles were plotted instead of the 5th and 95th percentiles. Although the lower and higher percentiles are provided in Table 4 , due to the noise floor limitations (in which SNR is set to 0 dB), the 10th and 90th percentiles are considered to be more reliable for clinical normative purposes. DPOAE levels at visit 1 were similar in the overall shape to visit 3, except for a higher peak in the level at 1.5 and 4 kHz. By visit 3, the median DPOAE levels displayed a more mature (e.g., flatter) shape with a gradual decline with increased f 2 test frequency (except for a small relative maximum at 4 kHz). At most f 2 frequencies (i.e., above 1.5 kHz), the median SNR decreased from visit 1 to 3. The SNR was smallest in the low frequencies in both age ranges due to increased noise, and the SNR improved as the f 2 test frequency increased to 8 kHz.
DISCUSSION
As this is the first large scale longitudinal study to focus on changes in DPOAE responses during the early developmental period from birth to 15 months of age, there are limited data for comparison. Many published studies used different stimulus parameters (L 1 , L 2 , f 2 test frequencies, and f 2 /f 1 ) or studied different populations including newborns, older children, and adults (Gorga et al. 1997; Lasky 1998; Abdala & Dhar 2012) . In addition, several studies combined infants from birth to 1 year of age into a single age range (Prieve et al. 1997; Kon et al. 2000) . Fig. 2 . Illustration of the raw data for DPOAE level (A) and SNR distributions (B) based on percentile rankings from normal-hearing infants in younger and older age groups. The light shaded area represents the 10th to 90th percentile, and the dark shaded area represents the 20th to 80th percentile. The dark black line represents the median or 50th percentile. The percentiles used in this figure are reported in Table 4 . DPOAE indicates distortion product otoacoustic emission; SNR, signal to noise ratio.
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These combined age ranges may not be appropriate due to the extensive developmental changes in the external and middle ear that occur over the first 4 months, which contribute to maturational changes in DPOAE level and SNR.
Normal Longitudinal Development of DPOAEs
DPOAE Level • The present study found significant changes in mean DPOAE level from birth to 15 months of age. In general, DPOAE levels were the highest at visit 1a (1 month) and decreased with age. At visits 1a and 1b (0 to 4 months of age), a peak in DPOAE levels occurred at f 2 frequencies of 1.5 and 4 kHz. The largest decrease in DPOAE level, about 5 dB, occurred between visits 1 and 2 in the mid to high frequencies (4, 5.5, 8 kHz) . No significant changes in DPOAE level occurred from visits 2 to 4 (between 5 and 15 months of age). These changes are consistent with the time course of major earcanal and middle ear development that occur mainly from birth to 6 months of age. With respect to stimulus parameters and population, the present study is most similar to the report by Abdala et al. (2008) , plotted in Figure 3 for mean DPOAE levels in infants from birth to 3 months (Fig. 3A) and 6 months of age (Fig. 3B) . Mean adult DPOAE levels are also plotted in Figures 3A, B for reference . The mean DPOAE levels reported by Abdala et al. are similar to those obtained in the present study at similar ages. In Figure 3A , mean DPOAE levels in infants at birth and 1 month of age are within 2 dB at lower (1.5 to 3 kHz) and higher (5.5 and 8 kHz) f 2 frequencies. However at 4 kHz, the mean DPOAE level presented in the present study is approximately 5.5 dB SPL higher than the mean DPOAE level reported by Abdala et al. at 6 kHz. DPOAE levels at 2 months from the present study and 3 months reported by Abdala et al. are within 1.5 dB SPL with the exception of 8 kHz, where Abdala et al. reported DPOAE levels 3 dB SPL higher than the present study. At 6 months of age (Fig. 3B) , DPOAE level differences between the present study and Abdala et al. are less than 1 dB SPL for f 2 frequencies from 1.5 to 3 kHz. However for f 2 frequencies from 4 to 8 kHz, Abdala et al. reported mean DPOAE levels that ranged from 1.5 to 4 dB SPL higher than reported in the present study. Given the different test instruments and populations studied, these results show extensive similarities across age group and frequency.
Compared with adult DPOAE levels, infants displayed consistently higher mean DPOAE levels for all f 2 frequencies. Mean DPOAE levels at visit 1 were 3 to 13 dB higher than adults; however, by visit 2, the mean difference ranged from 1 to 7.6 dB. These results are consistent with previous studies that reported that DPOAE levels in preterm (24 to 37 weeks) and term infants (>37 weeks) at birth were approximately 2 to 10 dB higher than adults (Lafreniere et al. 1991; Bonfils et al. 1992; Lasky et al. 1992; Smurzynski et al. 1993; .
With respect to the pattern of DPOAE level across frequency, several other published studies have described peaks in infant DPOAE levels at various f 2 frequencies. Abdala et al. (2008) reported a peak present at 1.5 to 2 kHz, and another at 4.5 to 6 kHz, in infant ears from birth to 6 months of age. Others have reported dips or reduced DPOAE levels in the mid-frequency region from 3.4 to 4 kHz (Lafreniere et al. 1991; Smurzynski et al. 1993) . Kon et al. (2000) reported peaks in DPOAE levels at 1.6 and 5.0 kHz with decreased responses in the mid-and high-frequency range. A peak in DPOAE level is typically seen Fig. 3 . Mean (raw data) DPOAE levels are plotted as a function of f 2 frequency for infants from the present study, Abdala et al. (2008) , and Gorga et al. (1997) . A, Results from birth to 3 mos of age. B, Results from infants at 6 mos of age. Adult DPOAE levels are displayed in both panels (A and B) for comparison. DPOAE indicates distortion product otoacoustic emission. & HEARING, VOL. 39, NO. 5, [863] [864] [865] [866] [867] [868] [869] [870] [871] [872] [873] 871 in adults at lower f 2 frequencies (<2 kHz) with a gradual reduction in DPOAE response in the mid-to high-frequency range (Lasky et al. 1992; Smurzynski et al. 1993; Gorga et al. 1996) . Overall, adult DPOAE patterns across frequency are typically flatter with fewer peaks and less variation across f 2 frequency than responses obtained from infants (Lasky et al. 1992; Gorga et al. 1996 Gorga et al. , 1997 . Differences in the in situ stimulus calibration methods across manufacturers may account for some of the differences observed, but the frequency pattern for DPOAE levels is relatively consistent across the present and other available studies in infants. Thus, these characteristic peaks and valleys likely represent different ear-canal and middle ear transmission effects in the infant ear (Keefe & Abdala 2007) . DPOAE Noise Level • The DPOAE noise level increased slightly with age over the first year with the highest noise levels seen in the 12-month-old group across test frequencies (see Fig. 1 ). Mean DPOAE noise levels were higher in the low frequencies and progressively decreased as test frequency increased. At low frequencies (f 2 = 1.0 and 1.5 kHz), noise levels were on average 18 dB higher than at the f 2 frequency with the lowest noise level (f 2 = 8.0 kHz). This pattern was consistent across all five age ranges (1, 2, 6, 9, and 12 months in Fig. 1 ).
HUNTER ET AL. / EAR
The present results are consistent with previous studies that have shown that noise levels tend to decrease with increasing frequency (Gorga et al. 1993b; Bergman et al. 1995; Prieve et al. 1997) and that noise levels are higher in infants than adults (Gorga et al. 1993a) . We observed that older infants were noisier due to body movement and because they were much less likely to sleep during testing than were young infants. Gorga et al. (1993a) reported mean noise levels in adults that ranged from 14 dB SPL (f 2 = 0.5 kHz) to −25 dB SPL (f 2 = 3.9 kHz). However, in the 1 to 8 kHz frequency range, the mean noise levels in adults ranged from approximately −6 dB SPL (f 2 = 1.0 kHz) to −23 dB SPL (f 2 = 8.0 kHz), which are much lower than the mean DPOAE noise levels reported in the present study of 6.5 to −11.9 dB SPL, respectively (see Fig. 1 ). Abdala et al. (2008) reported mean DPOAE noise levels that ranged from 1.5 dB SPL (f 2 = 1.5 kHz) to −15 dB SPL (f 2 = 9.0 kHz), slightly lower than those reported in the present study. Different manufacturers use different hardware, stimuli, and noise averaging algorithms; therefore, some quantitative differences in noise levels are to be expected. Notwithstanding that fact, the overall pattern of higher noise levels in infants and for lower frequencies is consistent across studies. The test frequency order we followed (from high to low frequencies) was most commonly used in clinical practice to make results more clinically applicable. However, this order of testing could introduce order effects, in which noise in the lower frequencies may be more affected by noise if the infant becomes noisier. In contrast, some infants become less noisy as they settle down after probe insertion, so test order effects could go in either direction. Because we did not randomize or counterbalance test order, this is a limitation of the results. Differences in noise levels between infants and adults may be attributed to several factors. First, infants tend to breathe more rapidly and noisily than adults. Ear-canal noise generated by blood flow may be larger in infants than adults because the vibratory motion of the blood may be more directly coupled to the middle ear cavity in the infant than in an adult. Spontaneous OAEs in adult ears are modulated by heartbeat (Long & Talmadge 1997) , and this variability may contribute to the noise levels of other types of OAE measurements. Blood-flow effects have been reported in infants for TEOAE (Rubens et al. 2008) and DPOAE (Keefe et al. 2008) . Because the infant ear-canal wall is highly compliant, breathing and blood-flow noise may not be attenuated as much as in the adult ear canal. The Eustachian tube is open at rest in infants, while it is closed in adults, so nasopharyngeal noise is likely higher in infants. Finally, it can be harder to maintain a good probe seal in infants due to movement, crying, and yawning. This may result in increased ambient noise entering the ear canal and decreased stimulus levels, which may increase the DPOAE noise levels and decrease the DPOAE level, if the probe is not refit as needed. This issue can be more apparent in older infants because they are more awake and mobile than newborns. Because noise levels are highly frequency dependent and are greater in infants than adults, reliable DPOAE SNR is easier to achieve clinically for higher f 2 frequencies, for example, at 2 kHz and higher, consistent with previous studies across a wide age range (Gorga et al. 2000b; Keefe et al. 2003b) . Why Are DPOAE Levels Larger in Infants? • The observation of larger DPOAE levels in infants compared with adults can most likely be attributed to the anatomical and related functional immaturities of the ear canal and middle ear (Keefe & Abdala 2007) , and to any differences in the calibration of the sound stimuli in the ear canal. There are substantial anatomical and maturational differences between the infant and adult earcanal and middle ear cavity that can affect the forward transmission of the DPOAE stimulus and reverse measurement of the DPOAE level. In general, the infant ear-canal cavity has a smaller cross-sectional area than in adults (Keefe & Abdala 2007) , the tympanic membrane has a more horizontal orientation, and the ear-canal wall is more compliant than in adults (Ikui et al. 1997 ). These differences may affect stimuli that are delivered through the middle ear and the DPOAE response measured in the ear canal that are not accounted for in the in situ volume calibration techniques. One important example is that ear-canal wall mobility effects are most important at frequencies below 1 kHz in infants younger than about 6 months of age (Hunter et al. 2016) . Keefe and Abdala (2007) described a model of acoustical and mechanical transmission through external, middle, and inner ear to understand why DPOAE suppression responses at an f 2 frequency of 6 kHz differed in infants relative to adults. This is the test frequency at which maturational differences in DPOAE suppression tuning curves are largest. Based on the assumption that cochlear function was adult like at birth, the model decomposed DPOAE response contributions into ear-canal and middle ear components. Their main findings were that infant middle ear immaturities result in an attenuation in the forward transmission of the stimulus, and immaturities in the infant ear canal contribute in an overall gain in the DPOAE responses. Hunter et al. (2016) reported that estimates of ear-canal length, which are influenced by ear-canal wall mobility and the relative angle of the tympanic membrane, are not adult like until 6 months of age. Although in situ calibration of the stimuli generating the DPOAE signal partially accounts for ear-canal volume differences, the calibration assumes that the ear canal is a cylindrical, hard-walled cavity. Moreover, the reverse transmission of the DPOAE in the infant ear increases the DPOAE level because it drives into a smaller ear-canal volume. The assumption of a hard-wall ear canal holds in adults, but the walls of the infant ear canal are soft and absorb more sound energy, especially for lower frequencies. Thus, the in situ calibration is likely insufficient to completely account for infant-adult ear canal differences.
Other potential explanations that have not been thoroughly researched include subtle immaturities of the descending medial efferent fiber innervation of the OHCs (Lavigne-Rebillard & Pujol 1990), although Abdala et al. (2008) suggest that the auditory efferents may be mature at birth. Immaturities of the mass and stiffness properties of the sensory epithelium, and supernumerary hair cells within the cochlea at birth may be a factor (Bredberg et al. 1965; Igarashi 1980; Lavigne-Rebillard & Pujol 1986) . Perhaps most importantly, infants are less likely to have been exposed to environmental factors, such as noise and ototoxins that could result in damage to the OHCs without a reduction in audiometric thresholds, thus their cochleae are pristine in comparison to older children and adults. All these factors have the potential to affect the generation of DPOAEs.
Limitations and Future Directions
There are some limitations in the present study, including that equipment from only one manufacturer was studied, the need to complete in situ calibration at individual test frequencies, and need to compare results to infants with defined hearing loss. Differences in algorithms for noise reduction exit among different manufacturers, and these algorithms are proprietary. Thus, differences in methodologies across studies may constrain the generalizability of our results on the noise level, and thus on SNR. These data are useful for determining effects due to age in a population that is similar in age to infants at greater risk for hearing loss, but to determine the effectiveness of DPOAE for detection of hearing loss in this age group, analysis of ears with defined hearing loss is required. A companion study (Blankenship et al., Reference Note 1) that includes infants with conductive, sensorineural, and mixed hearing loss was completed to address this issue.
CONCLUSION/SUMMARY
Hearing impairment is one of the most common disabilities reported in infants. Early identification of hearing loss combined with an immediate age-appropriate intervention is essential for speech and language development. DPOAEs are a commonly used diagnostic tool to evaluate cochlear function; however, to maximize test performance, age-appropriate normative data are essential. This study reports longitudinal normative data and DPOAE level and SNR ranges that can be used to evaluate the clinical results from birth to 1 year of age. DPOAEs may be used to help determine the presence of mild and greater degrees of hearing loss, using clinical cut-off points that are reported in our companion article in infants with confirmed hearing loss (Blankenship et al., Reference Note 1) . In addition, threshold tests such as the ABR or a behavioral audiogram are necessary to confirm the degree, type, and configuration of hearing loss to guide rehabilitation plans.
